Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Oncology|July 11, 2001
S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cellsA Manni, S Fischer, M Franks, et al.
Cancer|April 1, 1984
Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinomaJ R Drago, R J Santen, A Lipton, et al.
Anticancer Research|March 1, 1985
Hormone stimulation and chemotherapy in advanced prostate cancer: preliminary results of a prospective controlled clinical trialA Manni, R J Santen, A Boucher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Alpha-difluoromethylornithine as treatment for metastatic breast cancer patientsJ A O'Shaughnessy, L M Demers, S E Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcomeA Manni, M Bartholomew, R Caplan, et al.
Journal of Neuroimmunology|January 4, 2017
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patientsD Paolicelli, A Manni, M D'Onghia, et al.
Journal of Steroid Biochemistry|January 1, 1987
Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancerA Manni, R J Santen, A E Boucher, et al.
Anticancer Research|May 1, 1984
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulationA Manni, R J Santen, A E Boucher, et al.
Anticancer Research|March 1, 1986
Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trialA Manni, R J Santen, A E Boucher, et al.
European Journal of Clinical Nutrition|June 7, 2012
Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trialC Signori, C DuBrock, J P Richie, et al.
Pageof 14